Grants and Contributions:
Title:
Manufacture of Counterflow Product Prototype to Treat Severe Abdominal Hemorrhage
Agreement Number:
905062
Agreement Value:
$50,000.00
Agreement Date:
Apr 1, 2018 - Feb 28, 2019
Description:
This project will involve the development of a product prototype for evaluation in treating severe bleeding in civilian and military trauma settings. Analytical assays for testing, manufacturing process of gauze coating and powder product, release of a CounterFlow prototype product will be established along with product stability/storage specifications._x000D_
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V7Y 1B3
Reference Number:
172-2018-2019-Q1-905062
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
701047128
Recipient Type:
For-profit organization
Recipient's Legal Name:
CoMotion Drug Delivery Systems Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710